🔗 Share this article Individuals Stopping Anti-Obesity Jabs Regain Pounds Four Times Faster Compared to Dieters Weight management often requires ongoing approaches. A recent study indicates that people who discontinue blockbuster slimming jabs like Wegovy and Mounjaro may regain shed pounds far faster than those who halt conventional lifestyle plans. Published data in a prominent medical journal points out that while obese individuals frequently drop substantial amounts of their body weight while on the medication, the weight comes back at an average rate of 0.8 kg per month once they quit. "People using such medications must be aware of the danger of rapid rebound weight gain when the treatment concludes," warns expert Dr. Susan Jebb. That rate of regain means a reversion to pre-treatment weight in about 18 months. Analyzing Therapies The study, which reviewed 37 of trials involving thousands of patients, compared the outcomes of these new drugs with other pills. Scientists emphasize that individuals who lose weight through dieting usually see a less rapid creep back—perhaps 100 grams monthly—once they finish. Explaining the Quick Rebound Nutrition scientists believe the mode of action of the injections is key to understanding the accelerated regain. These medications imitate a body's own chemical called glucagon-like peptide-1, which moderates feelings of fullness. "Sustained high doses of GLP-1 levels several times higher than normal might result in the body to generate a reduced amount of its own natural GLP-1, and could lessen responsiveness to its actions," noted Dr. Adam Collins, a nutrition researcher. "Stopping of this hormone supplement results in hunger is unsuppressed, making overeating much more probable." A Lifelong Disease? Medical guidelines advise the injections for individuals with weight-linked medical conditions, alongside prescribed diet and exercise modifications. Professionals contend that, given the likelihood of weight regain, the treatment is often ongoing. This perspective is supported by drug manufacturers, who say that the findings "underscore the long-term character of obesity," akin to managing conditions like diabetes. User Accounts People who have stopped the medication report a sudden resurgence of appetite. "I experienced a trigger that goes on and you become ravenous," described a patient. The struggle is exacerbated if users have not developed permanent dietary or behavioural modifications during treatment. Growing Interest Figures show that millions of people in the UK have tried weight-loss jabs in the past year, with interest remaining high. Use is more common among females compared to males. The 40s and 50s demographic shows the highest level of interest. Many obtain the medications through private healthcare rather than public health services. In conclusion, researchers stress that while the jabs are powerful agents for weight loss, they are not a standalone fix and lasting health benefits relies on integrated lifestyle management.
Weight management often requires ongoing approaches. A recent study indicates that people who discontinue blockbuster slimming jabs like Wegovy and Mounjaro may regain shed pounds far faster than those who halt conventional lifestyle plans. Published data in a prominent medical journal points out that while obese individuals frequently drop substantial amounts of their body weight while on the medication, the weight comes back at an average rate of 0.8 kg per month once they quit. "People using such medications must be aware of the danger of rapid rebound weight gain when the treatment concludes," warns expert Dr. Susan Jebb. That rate of regain means a reversion to pre-treatment weight in about 18 months. Analyzing Therapies The study, which reviewed 37 of trials involving thousands of patients, compared the outcomes of these new drugs with other pills. Scientists emphasize that individuals who lose weight through dieting usually see a less rapid creep back—perhaps 100 grams monthly—once they finish. Explaining the Quick Rebound Nutrition scientists believe the mode of action of the injections is key to understanding the accelerated regain. These medications imitate a body's own chemical called glucagon-like peptide-1, which moderates feelings of fullness. "Sustained high doses of GLP-1 levels several times higher than normal might result in the body to generate a reduced amount of its own natural GLP-1, and could lessen responsiveness to its actions," noted Dr. Adam Collins, a nutrition researcher. "Stopping of this hormone supplement results in hunger is unsuppressed, making overeating much more probable." A Lifelong Disease? Medical guidelines advise the injections for individuals with weight-linked medical conditions, alongside prescribed diet and exercise modifications. Professionals contend that, given the likelihood of weight regain, the treatment is often ongoing. This perspective is supported by drug manufacturers, who say that the findings "underscore the long-term character of obesity," akin to managing conditions like diabetes. User Accounts People who have stopped the medication report a sudden resurgence of appetite. "I experienced a trigger that goes on and you become ravenous," described a patient. The struggle is exacerbated if users have not developed permanent dietary or behavioural modifications during treatment. Growing Interest Figures show that millions of people in the UK have tried weight-loss jabs in the past year, with interest remaining high. Use is more common among females compared to males. The 40s and 50s demographic shows the highest level of interest. Many obtain the medications through private healthcare rather than public health services. In conclusion, researchers stress that while the jabs are powerful agents for weight loss, they are not a standalone fix and lasting health benefits relies on integrated lifestyle management.